Gerhardt, M.J.; Priglinger, C.S.; Rudolph, G.; Hufendiek, K.; Framme, C.; Jägle, H.; Salchow, D.J.; Anschütz, A.; Michalakis, S.; Priglinger, S.G.
Gene Therapy with Voretigene Neparvovec Improves Vision and Partially Restores Electrophysiological Function in Pre-School Children with Leber Congenital Amaurosis. Biomedicines 2023, 11, 103.
https://doi.org/10.3390/biomedicines11010103
AMA Style
Gerhardt MJ, Priglinger CS, Rudolph G, Hufendiek K, Framme C, Jägle H, Salchow DJ, Anschütz A, Michalakis S, Priglinger SG.
Gene Therapy with Voretigene Neparvovec Improves Vision and Partially Restores Electrophysiological Function in Pre-School Children with Leber Congenital Amaurosis. Biomedicines. 2023; 11(1):103.
https://doi.org/10.3390/biomedicines11010103
Chicago/Turabian Style
Gerhardt, Maximilian J., Claudia S. Priglinger, Günther Rudolph, Karsten Hufendiek, Carsten Framme, Herbert Jägle, Daniel J. Salchow, Andreas Anschütz, Stylianos Michalakis, and Siegfried G. Priglinger.
2023. "Gene Therapy with Voretigene Neparvovec Improves Vision and Partially Restores Electrophysiological Function in Pre-School Children with Leber Congenital Amaurosis" Biomedicines 11, no. 1: 103.
https://doi.org/10.3390/biomedicines11010103
APA Style
Gerhardt, M. J., Priglinger, C. S., Rudolph, G., Hufendiek, K., Framme, C., Jägle, H., Salchow, D. J., Anschütz, A., Michalakis, S., & Priglinger, S. G.
(2023). Gene Therapy with Voretigene Neparvovec Improves Vision and Partially Restores Electrophysiological Function in Pre-School Children with Leber Congenital Amaurosis. Biomedicines, 11(1), 103.
https://doi.org/10.3390/biomedicines11010103